SYRE
Spyre Therapeutics, Inc.
Company overview
- Market capitalization
- $7.56B
- Employees
- 112
- Latest publication
- 2026-09-29
About Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD) and rheumatic diseases. The company develops SPY001, a humanized monoclonal immunoglobulin G1 antibody that is in phase-2 clinical stage designed to bind selectively to the a4ß7 integrin being developed for the treatment of IBD (ulcerative colitis and Crohn's disease); and SPY002 and SPY072 " anti-TL1A mAbs designed to bind to tumor necrosis factor-like ligand 1A (TL1A). It is also developing SPY003, a clinical-stage program, which is in phase-2 clinical stage designed to bind to interleukin 23 (IL-23); SPY120, a combination of anti-a4ß7 and anti-TL1A mAbs; SPY130, a combination anti-a4ß7 and anti-IL-23 mAbs; and SPY230, a combination anti-TL1A and anti-IL-23 mAbs. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. The company was incorporated in 2013 and is based in Waltham, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 60,411,000USD | 45,247,000USD | 40,145,000USD | 41,623,000USD | 50,482,000USD | 44,744,000USD | 32,636,000USD | 34,928,000USD |
| Selling General Administrative | 15,230,000USD | 11,641,000USD | 11,790,000USD | 11,944,000USD | 10,771,000USD | 10,648,000USD | 11,511,000USD | 12,846,000USD |
| Total Operating Expenses | 75,641,000USD | 11,641,000USD | 41,935,000USD | 53,567,000USD | 61,253,000USD | 55,392,000USD | 44,147,000USD | 47,774,000USD |
| Operating Income | -75,641,000USD | -56,888,000USD | -41,935,000USD | -53,567,000USD | -61,253,000USD | -55,392,000USD | -44,147,000USD | -47,774,000USD |
| Interest Income | 6,995,000USD | 5,379,000USD | 5,874,000USD | 6,493,000USD | 5,776,000USD | 5,184,000USD | 5,920,000USD | 4,432,000USD |
| Net Interest Income | 6,995,000USD | 5,379,000USD | 5,874,000USD | 6,493,000USD | 5,776,000USD | 5,184,000USD | 5,920,000USD | 4,432,000USD |
| Income Before Tax | -69,005,000USD | -11,183,000USD | -36,717,000USD | -44,788,000USD | -56,295,000USD | -69,010,000USD | -38,837,000USD | -43,825,000USD |
| Tax Provision | 0USD | 0USD | 0USD | -15,000USD | 1,000USD | 18,000USD | 0USD | 32,000USD |
| Net Income | -69,005,000USD | -11,183,000USD | -36,717,000USD | -44,773,000USD | -56,296,000USD | -69,028,000USD | -38,837,000USD | -43,857,000USD |
| Net Income From Continuing Ops | -69,005,000USD | -11,183,000USD | -36,717,000USD | -44,773,000USD | -56,296,000USD | -69,028,000USD | -38,837,000USD | -43,857,000USD |
| Ebitda | -69,005,000USD | -11,183,000USD | -51,935,000USD | -44,788,000USD | -56,295,000USD | -69,010,000USD | -38,837,000USD | -43,825,000USD |
| Total Other Income Expense Net | 6,636,000USD | 45,705,000USD | 5,218,000USD | 8,779,000USD | 4,958,000USD | -13,618,000USD | 5,310,000USD | 3,949,000USD |
| Cost Of Revenue | — | 45,247,000USD | — | — | — | — | — | — |
| Gross Profit | — | -45,247,000USD | — | — | — | — | — | — |
| Unclassified Operating Expenses | — | -45,247,000USD | -10,000,000USD | — | — | — | — | — |
| Income Tax Expense | — | — | — | -15,000USD | 1,000USD | 18,000USD | — | 32,000USD |
| Interest Expense | — | — | — | — | 21,312,000USD | — | — | — |
| Ebit | — | — | — | — | -56,295,000USD | — | — | -47,817,276USD |
| Depreciation And Amortization | — | — | — | — | -4,958,000USD | — | — | 43,276USD |
| Reconciled Depreciation | — | — | — | — | 0USD | 0USD | 0USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 886,000USD | 886,000USD | 2,329,000USD | 18,739,000USD | 0USD | 0USD | 3,888,000USD |
| Cost Of Revenue | 171,653,000USD | 964,000USD | 964,000USD | 1,964,000USD | 2,001,000USD | 1,624,000USD | 901,000USD | — |
| Gross Profit | -171,653,000USD | 886,000USD | -78,000USD | 2,329,000USD | 18,739,000USD | -1,624,000USD | -901,000USD | 3,888,000USD |
| Research Development | 171,653,000USD | 162,790,000USD | 89,504,000USD | 58,579,000USD | 57,069,000USD | 59,638,000USD | 64,600,000USD | 36,719,000USD |
| Selling General Administrative | 47,909,000USD | 45,776,000USD | 39,946,000USD | 28,531,000USD | 27,319,000USD | 21,843,000USD | 17,801,000USD | — |
| Unclassified Operating Expenses | -181,653,000USD | — | 113,739,000USD | — | — | -1,624,000USD | -2,968,000USD | 12,632,000USD |
| Total Operating Expenses | 37,909,000USD | 208,566,000USD | 243,189,000USD | 87,110,000USD | 84,388,000USD | 79,857,000USD | 79,433,000USD | 49,351,000USD |
| Operating Income | -209,562,000USD | -208,566,000USD | -242,303,000USD | -84,781,000USD | -65,649,000USD | -81,481,000USD | -80,334,000USD | -45,463,000USD |
| Interest Income | 24,885,000USD | 21,312,000USD | 6,147,000USD | 837,000USD | 111,000USD | 593,000USD | 1,478,000USD | — |
| Net Interest Income | 24,885,000USD | 21,312,000USD | 6,147,000USD | 837,000USD | 111,000USD | 593,000USD | 1,478,000USD | — |
| Income Before Tax | -155,218,000USD | -207,967,000USD | -338,816,000USD | -83,951,000USD | -65,660,000USD | -80,893,000USD | -78,254,000USD | -44,348,000USD |
| Income Tax Expense | -15,000USD | 51,000USD | -26,000USD | -136,000USD | 141,000USD | -593,000USD | — | — |
| Tax Provision | -15,000USD | 51,000USD | -26,000USD | -136,000USD | 141,000USD | 0USD | — | — |
| Net Income | -155,203,000USD | -208,018,000USD | -338,790,000USD | -83,815,000USD | -65,801,000USD | -80,893,000USD | -78,254,000USD | -44,348,000USD |
| Net Income From Continuing Ops | -155,203,000USD | -208,018,000USD | -338,790,000USD | -83,815,000USD | -65,801,000USD | -80,893,000USD | -83,214,000USD | — |
| Ebit | -219,562,000USD | -128,564,000USD | -243,047,000USD | -83,951,000USD | -65,660,000USD | -80,893,000USD | -78,254,000USD | -45,463,000USD |
| Ebitda | -209,562,000USD | -207,967,000USD | -242,303,000USD | -81,987,000USD | -64,084,000USD | -79,269,000USD | -77,353,000USD | -45,170,000USD |
| Depreciation And Amortization | 10,000,000USD | 964,000USD | 744,000USD | 1,964,000USD | 1,576,000USD | 1,624,000USD | 901,000USD | 293,000USD |
| Reconciled Depreciation | 0USD | 0USD | 744,000USD | 1,567,000USD | 1,576,000USD | 996,000USD | 587,000USD | — |
| Total Other Income Expense Net | 54,344,000USD | 599,000USD | -96,513,000USD | 830,000USD | -11,000USD | 588,000USD | 2,080,000USD | 1,115,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,173,003,000USD | 763,953,000USD | 777,781,000USD | 504,604,000USD | 538,832,000USD | 569,778,000USD | 608,484,000USD | 421,089,000USD |
| Cash And Equivalents | 162,007,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 1,100,000,000USD | 741,467,000USD | 756,533,000USD | 486,198,000USD | 526,580,000USD | 564,820,000USD | 603,088,000USD | 414,227,000USD |
| Total Current Assets | 1,173,003,000USD | 763,953,000USD | 777,781,000USD | 504,604,000USD | 538,832,000USD | 569,768,000USD | 608,474,000USD | 421,079,000USD |
| Other Current Assets | 27,657,000USD | 17,886,000USD | 21,248,000USD | 18,406,000USD | 12,252,000USD | 4,948,000USD | 5,386,000USD | 6,852,000USD |
| Total Liabilities | 71,862,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 63,302,000USD | 85,162,000USD | 58,685,000USD | 46,274,000USD | 83,059,000USD | 70,678,000USD | 54,060,000USD | 57,539,000USD |
| Other Non Current Liabilities | 1,290,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 1,101,141,000USD | 670,811,000USD | 715,236,000USD | 455,100,000USD | 455,773,000USD | 482,610,000USD | 517,804,000USD | 327,390,000USD |
| Total Equity Including Noncontrolling Interest | 1,101,141,000USD | — | — | — | — | — | — | — |
| Common Stock | 16,000USD | 15,000USD | 15,000USD | 13,000USD | 13,000USD | 13,000USD | 13,000USD | 12,000USD |
| Retained Earnings | -1,232,840,000USD | -1,196,640,000USD | -1,127,635,000USD | -1,065,105,000USD | -1,053,922,000USD | -1,017,205,000USD | -972,432,000USD | -916,136,000USD |
| Accumulated Other Comprehensive Income | -2,396,000USD | -767,000USD | 869,000USD | 791,000USD | 454,000USD | 682,000USD | 180,000USD | 1,457,000USD |
| Total Liab | — | 93,142,000USD | 62,545,000USD | 49,504,000USD | 83,059,000USD | 87,168,000USD | 90,680,000USD | 93,699,000USD |
| Other Current Liab | — | 79,470,000USD | 49,781,000USD | 38,817,000USD | 79,347,000USD | 66,989,000USD | 53,394,000USD | 52,374,000USD |
| Capital Stock | — | 155,835,000USD | 155,835,000USD | 155,833,000USD | 155,833,000USD | 155,833,000USD | 155,833,000USD | 155,832,000USD |
| Cash | — | 97,185,000USD | 85,721,000USD | 64,897,000USD | 81,659,000USD | 48,493,000USD | 89,423,000USD | 71,580,000USD |
| Net Debt | — | -97,185,000USD | -85,721,000USD | -64,897,000USD | -81,659,000USD | -48,493,000USD | -89,423,000USD | -71,580,000USD |
| Short Term Investments | — | 644,282,000USD | 670,812,000USD | 421,301,000USD | 444,921,000USD | 516,327,000USD | 513,665,000USD | 342,647,000USD |
| Net Receivables | — | 4,600,000USD | — | 3,600,000USD | 3,500,000USD | — | — | — |
| Accounts Payable | — | 5,692,000USD | 8,904,000USD | 7,457,000USD | 3,712,000USD | 3,689,000USD | 666,000USD | 5,165,000USD |
| Common Stock Shares Outstanding | — | 346,045,000shares | 346,045,000shares | 60,414,223shares | 60,696,550shares | 60,265,932shares | 47,027,638shares | 50,889,433shares |
| Non Current Assets Total | — | 0USD | 0USD | 0USD | 0USD | 10,000USD | 10,000USD | 10,000USD |
| Non Current Liabilities Total | — | 7,979,999USD | 3,860,000USD | 3,230,000USD | 0USD | 16,490,000USD | 36,620,000USD | 36,160,000USD |
| Non Current Liabilities Other | — | 7,980,000USD | 3,860,000USD | 3,230,000USD | — | 16,490,000USD | 36,620,000USD | 36,160,000USD |
| Net Working Capital | — | 678,791,000USD | 719,096,000USD | 458,330,000USD | 455,773,000USD | 499,090,000USD | 554,414,000USD | 363,540,000USD |
| Unclassified Equity | — | 1,712,368,000USD | 1,686,152,000USD | 1,363,568,000USD | 1,353,395,000USD | 1,343,287,000USD | 1,334,210,000USD | 1,086,225,000USD |
| Non Currrent Assets Other | — | — | — | — | — | 10,000USD | 10,000USD | 10,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 777,781,000USD | 608,484,000USD | 341,859,000USD | 71,144,000USD | 109,926,000USD | 161,618,000USD | 83,183,000USD | 77,739,000USD |
| Other Current Assets | 21,248,000USD | 5,386,000USD | 2,251,000USD | 6,172,000USD | 4,948,000USD | 3,516,000USD | 2,556,000USD | 2,158,000USD |
| Total Liab | 62,545,000USD | 90,680,000USD | 157,843,000USD | 20,839,000USD | 25,985,000USD | 21,786,000USD | 23,102,000USD | 10,311,000USD |
| Total Stockholder Equity | 715,236,000USD | 517,804,000USD | 184,016,000USD | 50,305,000USD | 83,941,000USD | 139,832,000USD | 60,081,000USD | 67,428,000USD |
| Other Current Liab | 49,781,000USD | 53,394,000USD | 31,082,000USD | 12,837,000USD | 14,030,000USD | 464,000USD | 14,826,000USD | 9,576,000USD |
| Common Stock | 15,000USD | 13,000USD | 10,000USD | 6,000USD | 5,000USD | 5,000USD | 3,000USD | 2,000USD |
| Capital Stock | 155,835,000USD | 155,833,000USD | 184,937,000USD | 6,000USD | 5,000USD | 5,000USD | 3,000USD | — |
| Retained Earnings | -1,127,635,000USD | -972,432,000USD | -764,414,000USD | -425,624,000USD | -341,809,000USD | -276,008,000USD | -195,115,000USD | -116,861,000USD |
| Cash | 85,721,000USD | 89,423,000USD | 188,893,000USD | 34,863,000USD | 15,142,000USD | 90,095,000USD | 19,253,000USD | 22,461,000USD |
| Cash And Short Term Investments | 756,533,000USD | 603,088,000USD | 339,277,000USD | 55,711,000USD | 93,128,000USD | 146,273,000USD | 71,949,000USD | 74,513,000USD |
| Total Current Assets | 777,781,000USD | 608,474,000USD | 341,528,000USD | 62,258,000USD | 98,891,000USD | 149,789,000USD | 74,505,000USD | 76,671,000USD |
| Total Current Liabilities | 58,685,000USD | 54,060,000USD | 31,978,000USD | 14,656,000USD | 20,144,000USD | 16,443,000USD | 18,359,000USD | 10,239,000USD |
| Net Debt | -85,721,000USD | -89,423,000USD | -104,338,000USD | -30,234,000USD | -10,082,000USD | -84,647,000USD | -14,131,000USD | -22,461,000USD |
| Short Term Investments | 670,812,000USD | 513,665,000USD | 150,384,000USD | 20,848,000USD | 77,986,000USD | 56,178,000USD | 52,696,000USD | 52,052,000USD |
| Accounts Payable | 8,904,000USD | 666,000USD | 896,000USD | 677,000USD | 3,319,000USD | 2,254,000USD | 3,154,000USD | 663,000USD |
| Accumulated Other Comprehensive Income | 869,000USD | 180,000USD | 302,000USD | -48,000USD | -20,000USD | 11,000USD | 51,000USD | -27,000USD |
| Common Stock Shares Outstanding | 346,045,000shares | 47,027,638shares | 6,897,065shares | 3,371,231shares | 2,629,784shares | 2,134,869shares | 1,277,985shares | 832,902shares |
| Non Current Assets Total | 0USD | 10,000USD | 331,000USD | 8,886,000USD | 11,035,000USD | 11,829,000USD | 8,678,000USD | 1,068,000USD |
| Non Current Liabilities Total | 3,860,000USD | 36,620,000USD | 125,865,000USD | 6,183,000USD | 5,841,000USD | 5,343,000USD | 4,742,999USD | 72,000USD |
| Non Current Liabilities Other | 3,860,000USD | 36,620,000USD | 41,310,000USD | — | 16,000USD | 214,000USD | 31,000USD | — |
| Net Working Capital | 719,096,000USD | 554,414,000USD | 309,550,000USD | 47,602,000USD | 78,747,000USD | 133,346,000USD | 56,146,000USD | — |
| Unclassified Equity | 1,686,152,000USD | 1,334,210,000USD | 763,181,000USD | 475,965,000USD | 425,760,000USD | 415,819,000USD | 255,139,000USD | 184,314,000USD |
| Short Long Term Debt Total | — | 84,555,000USD | 84,555,000USD | 4,629,000USD | 5,060,000USD | 5,448,000USD | 5,122,000USD | — |
| Non Currrent Assets Other | — | 10,000USD | 9,000USD | 683,000USD | 842,000USD | 115,000USD | 11,000USD | 50,000USD |
| Property Plant Equipment Net | — | — | 0USD | 6,650,000USD | 8,355,000USD | 9,872,000USD | 7,167,000USD | 1,018,000USD |
| Property Plant Equipment Gross | — | — | 0USD | 10,794,000USD | 11,157,000USD | 11,855,000USD | 7,111,000USD | — |
| Unclassified Non Current Liabilities | — | — | 84,555,000USD | 6,183,000USD | 5,825,000USD | 5,129,000USD | 4,711,999USD | — |
| Current Deferred Revenue | — | — | — | 517,000USD | 2,359,000USD | 13,406,000USD | — | — |
| Short Term Debt | — | — | — | 625,000USD | 436,000USD | 319,000USD | 379,000USD | — |
| Net Receivables | — | — | — | 375,000USD | 815,000USD | — | — | 300,000USD |
| Unclassified Non Current Assets | — | — | — | 1,553,000USD | 1,838,000USD | 1,842,000USD | 1,500,000USD | — |
| Other Assets | — | — | — | — | — | — | — | 1USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Stock Based Compensation | 26,318,000USD |
| Change To Liabilities | 225,000USD |
| Change In Working Capital | -5,841,000USD |
| Operating Cash Flow | -127,249,000USD |
| Net Investments | -311,323,000USD |
| Unclassified Investing Cash Flow | 70,000,000USD |
| Investing Cash Flow | -241,323,000USD |
| Common Stock Issuance | 23,255,000USD |
| Unclassified Financing Cash Flow | 421,603,000USD |
| Financing Cash Flow | 444,858,000USD |
| Change In Cash | 76,286,000USD |
| End Cash Flow | 162,007,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -69,005,000USD | -51,831,000USD | -11,183,000USD | -36,717,000USD | -44,773,000USD | -56,296,000USD | -69,028,000USD | -38,837,000USD |
| Stock Based Compensation | 12,806,000USD | 9,811,000USD | 9,566,000USD | 9,378,000USD | 8,859,000USD | 9,216,000USD | 13,100,000USD | 8,682,000USD |
| Other Non Cash Items | 11,218,000USD | 7,797,000USD | -41,440,000USD | -10,183,000USD | -4,512,000USD | -917,000USD | 16,156,000USD | -2,937,000USD |
| Change In Working Capital | 244,000USD | -2,265,000USD | 5,940,000USD | -9,041,000USD | -568,000USD | 10,798,000USD | 10,351,000USD | -29,156,000USD |
| Total Cash From Operating Activities | -57,543,000USD | -44,578,000USD | -37,117,000USD | -46,563,000USD | -40,994,000USD | -37,199,000USD | -29,421,000USD | -62,248,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -57,543,000USD | -44,578,000USD | -37,117,000USD | -46,563,000USD | -40,994,000USD | -37,199,000USD | -29,421,000USD | -62,248,000USD |
| Investments | 26,581,000USD | -247,410,000USD | 24,998,000USD | 78,998,000USD | -61,000USD | -170,544,000USD | 42,740,000USD | -120,518,000USD |
| Total Cashflows From Investing Activities | 56,581,000USD | -247,410,000USD | 24,998,000USD | 78,998,000USD | -61,000USD | -170,544,000USD | 42,740,000USD | -120,518,000USD |
| Total Cash From Financing Activities | 12,426,000USD | 312,812,000USD | -4,643,000USD | 731,000USD | 125,000USD | 225,601,000USD | 12,780,000USD | 360,000USD |
| Issuance Of Capital Stock | 9,750,000USD | 311,132,000USD | 0USD | 0USD | 0USD | 224,622,000USD | 11,540,000USD | -135,000USD |
| Change In Cash | 11,464,000USD | 20,824,000USD | -16,762,000USD | 33,166,000USD | -40,930,000USD | 17,843,000USD | 26,115,000USD | -182,408,000USD |
| Begin Period Cash Flow | 85,721,000USD | 64,897,000USD | 81,659,000USD | 48,493,000USD | 89,423,000USD | 71,580,000USD | 45,465,000USD | 227,552,000USD |
| End Period Cash Flow | 97,185,000USD | 85,721,000USD | 64,897,000USD | 81,659,000USD | 48,493,000USD | 89,423,000USD | 71,580,000USD | 45,144,000USD |
| Other Cashflows From Investing Activities | 30,000,000USD | — | — | 7,000,000USD | — | — | — | — |
| Unclassified Operating Cash Flow | -12,806,000USD | — | — | — | — | 11,404,000USD | — | — |
| Unclassified Financing Cash Flow | 2,676,000USD | 312,764,000USD | — | — | — | — | -168,850,000USD | — |
| Depreciation | — | -8,090,000USD | — | — | — | -11,404,000USD | 0USD | 0USD |
| Sale Purchase Of Stock | — | 117,000USD | — | 0USD | -117,000USD | — | — | 0USD |
| Other Cashflows From Financing Activities | — | -69,000USD | -5,134,000USD | -117,000USD | 242,000USD | 979,000USD | 170,090,000USD | 495,000USD |
| Unclassified Investing Cash Flow | — | — | — | -7,000,000USD | — | — | — | — |
| Net Borrowings | — | — | — | — | — | 0USD | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -155,203,000USD | -208,018,000USD | -338,790,000USD | -83,815,000USD | -65,801,000USD | -80,893,000USD | -78,254,000USD | -44,348,000USD |
| Depreciation | -8,090,000USD | 744,000USD | 744,000USD | 1,567,000USD | 1,576,000USD | 996,000USD | 901,000USD | 293,000USD |
| Stock Based Compensation | 37,614,000USD | 44,833,000USD | 25,675,000USD | 7,111,000USD | 8,038,000USD | 6,256,000USD | 5,498,000USD | — |
| Other Non Cash Items | -37,639,000USD | 10,309,000USD | 217,667,000USD | 823,000USD | 638,000USD | 619,000USD | 3,776,000USD | 1,930,000USD |
| Change In Working Capital | -5,934,000USD | -4,534,000USD | -5,206,000USD | -5,503,000USD | 1,833,000USD | -2,540,000USD | 7,104,000USD | 7,201,000USD |
| Total Cash From Operating Activities | -169,252,000USD | -157,410,000USD | -99,910,000USD | -80,144,000USD | -53,716,000USD | -75,775,000USD | -65,692,000USD | -32,193,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | -38,000USD | -573,000USD | -4,280,000USD | -1,492,000USD | -422,000USD |
| Free Cash Flow | -169,252,000USD | -157,410,000USD | -99,910,000USD | -80,182,000USD | -54,289,000USD | -80,055,000USD | -67,184,000USD | -32,615,000USD |
| Investments | -150,475,000USD | -353,285,000USD | -108,393,000USD | 57,008,000USD | -22,619,000USD | -7,604,000USD | -15,670,000USD | — |
| Total Cashflows From Investing Activities | -143,475,000USD | -353,285,000USD | — | 57,008,000USD | -22,619,000USD | -7,604,000USD | -1,739,000USD | -15,231,000USD |
| Total Cash From Financing Activities | 309,025,000USD | 410,906,000USD | 361,077,000USD | 42,678,000USD | 1,393,000USD | 154,512,000USD | 65,723,000USD | 57,068,000USD |
| Issuance Of Capital Stock | 311,132,000USD | 405,232,000USD | 366,474,000USD | 42,874,000USD | 0USD | 153,716,000USD | 129,250,000USD | — |
| Change In Cash | -3,702,000USD | -99,792,000USD | 152,799,000USD | 19,436,000USD | -74,957,000USD | 71,184,000USD | -3,208,000USD | 9,644,000USD |
| Begin Period Cash Flow | 89,423,000USD | 189,215,000USD | 36,416,000USD | 16,980,000USD | 91,937,000USD | 20,753,000USD | 22,461,000USD | 12,817,000USD |
| End Period Cash Flow | 85,721,000USD | 89,423,000USD | 189,215,000USD | 36,416,000USD | 16,980,000USD | 91,937,000USD | 19,253,000USD | 22,461,000USD |
| Other Cashflows From Investing Activities | 7,000,000USD | 15,475,000USD | — | — | — | — | — | — |
| Other Cashflows From Financing Activities | -5,413,000USD | 174,524,000USD | 191,983,000USD | 222,000USD | 1,903,000USD | 816,000USD | 1,450,000USD | 3,020,000USD |
| Unclassified Financing Cash Flow | 3,306,000USD | -168,850,000USD | -197,364,000USD | — | — | — | -64,977,000USD | 54,048,000USD |
| Change To Account Receivables | — | 375,000USD | 375,000USD | 440,000USD | -815,000USD | — | — | 3,078,000USD |
| Net Borrowings | — | 0USD | -16,000USD | -418,000USD | -510,000USD | — | — | — |
| Unclassified Investing Cash Flow | — | -15,475,000USD | — | — | — | 4,280,000USD | 15,423,000USD | -14,809,000USD |
| Change To Inventory | — | — | -375,000USD | -440,000USD | — | — | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | -4,717,000USD | 2,731,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2023Yearly · 2023-12-31 | Product | Development Fee And Royalty | 886,000 | USD | 0001636282-24-000005 |
| FY 2023Yearly · 2023-12-31 | Product | License | 0 | USD | 0001636282-24-000005 |
| FY 2022Yearly · 2022-12-31 | Product | Development Fee And Royalty | 2,329,000 | USD | 0001636282-24-000005 |
| FY 2022Yearly · 2022-12-31 | Product | License | 0 | USD | 0001636282-24-000005 |
| Q3 2022Quarterly · 2022-09-30 | Product | Development Fee | 174,000 | USD | 0000950170-22-021529 |
| Q3 2022Quarterly · 2022-09-30 | Product | License | 0 | USD | 0000950170-22-021529 |
| FY 2021Yearly · 2021-12-31 | Product | Development Fee And Royalty | 6,739,000 | USD | 0001636282-24-000005 |
| FY 2021Yearly · 2021-12-31 | Product | License | 12,000,000 | USD | 0001636282-24-000005 |
| Q3 2021Quarterly · 2021-09-30 | Product | Development Fee | 1,399,000 | USD | 0000950170-22-021529 |
| Q3 2021Quarterly · 2021-09-30 | Product | License | 0 | USD | 0000950170-22-021529 |
| Q2 2021Quarterly · 2021-06-30 | Product | Development Fee | 1,696,000 | USD | 0001564590-22-027895 |
| Q2 2021Quarterly · 2021-06-30 | Product | License | 12,000,000 | USD | 0001564590-22-027895 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.